Résumé
This project outlined use of the diffusion of innovations model to disseminate bone marrow transplantation technology for the cure of sickle cell anemia and other hemoglobinopathies. Besides, we Identified technologically developed nations that have the relevant medical workforce and infrastructures for BMT. Also discussed, is the necessity of equipping transplant facilities with the construction of the CLEAN ROOM with the state- of- the science resources to protect SCD patients from nosocomial infections. To save human lives and avoid unnecessary casualties, the medical team must protect their patients from hospital acquired infections (HAI), nosocomial and iatrogenic diseases during administration of transplant innovative device. Medical institutions must maintain continuity in sustainable, scientific workforce development. Finally, we explored the ethical, legal, social, and financial implications of adopting Bone Marrow Transplantation medical innovations to cure sickle cell anemia.